Latest News | Glenmark Gets USFDA Nod for Generic Drug Used to Treat Mental Disorder

New Delhi, Nov 7 (PTI) Glenmark Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic Fluphenazine Hydrochloride tablets used to treat certain types of mental disorders.

The approval granted by the US Food & Drug Administration (US FDA) is for Fluphenazine Hydrochloride tablets of strengths 1 mg, 2.5 mg, 5 mg and 10 mg, Glenmark said in a statement.

Also Read | Maratha Reservation Row: Activist Manoj Jarange-Patil Targets Maharashtra Minister Chhagan Bhujbal, Says He Is Losing OBC Base.

These are the generic versions of Prolixin tablets in same strengths of Apothecon Inc, it added.

The company's Fluphenazine Hydrochloride tablets will be distributed in the US by Glenmark Pharmaceuticals Inc, USA, it said.

Also Read | SSC Delhi Police Constable Admit Card 2023 Released At ssc.nic.in, Know How to Download Hall Ticket.

For the 12 months ended September 2023, Prolixin tablets in the same strengths achieved annual sales of approximately USD 18.1 million, Glenmark said citing IQVIA data.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)